Pharmafile Logo

Amici Procurement Solutions

Amici provide cutting edge sourcing solutions to companies across the Biotech industry. Our business is to deliver greater savings through improved supplier performance. We can support you whether you are looking for an outsourced procurement resource or simply to save money quickly. We offer consortium deals, consultancy, training and a virtual purchasing resource. Uniquely, we also provide a savings guarantee.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

3 Centura Court, Nasmyth Place, Glasgow, G52 4PR
+44 (0)141 810 2580

 Latest Content from PMHub 

#Wellbeing Week: Let’s tackle pressure

White Papers and Resources | October 13, 2022 | Fox&Cat

Hear from Paul Hutchings, founder of foxandcat.online, with tips and advice to help your comms team thrive under pressure

The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia

With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20...

Infographic: Therapy Watch Psoriasis

White Papers and Resources | October 10, 2022 | Inizio

Our PsO infographic offers an introduction to the real-world patient insights collected by our Therapy Watch PsO study.

Porterhouse Insights celebrates its 5th anniversary

Porterhouse Medical Group is celebrating the 5th anniversary of Porterhouse Insights, its global research, insights and evidence consultancy.

Thought Leaders in Medical Affairs: Key Trends & Challenges Shaping the Future of the Medical Affairs Role

How can Medical Affairs divisions bring greater value to their organizations and practitioners every day?

Mobilizing Agitation Detection in Children with ADHD

Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...

Onyx Health Goes for International Growth with New Managing Director

Press Releases | October 6, 2022 | Onyx Health

Onyx Health has announced the appointment of Trevor Pill as their new Managing Director. He will be taking over the day-to-day running of the agency from owner and founder Karen...

Lifting the fog to help Clinical Labs navigate IVDR 2022

In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests.  BD wanted to let their customers...

Empowering adolescents to manage emotional and mental health issues

1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...

Reframing rare to increase earlier diagnosis of Gaucher Disease

Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...